UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials Journal article
Lyu, Liyang, Feng, Ye, Huang, Borong, Xu, Ren He, Hu, Yuanjia. Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials[J]. Nature Biotechnology, 2024, 42(4), 563-569.
Authors:  Lyu, Liyang;  Feng, Ye;  Huang, Borong;  Xu, Ren He;  Hu, Yuanjia
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:33.1/56.9 | Submit date:2024/05/02
Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials Journal article
Zhang, Daiyan, Lyu, Liyang, Han, Shuo, Xu, Jiaqi, Hu, Guang, Zhao, Qi, Hu Yuanjia. Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials[J]. International Immunopharmacology, 2024, 126, 111273.
Authors:  Zhang, Daiyan;  Lyu, Liyang;  Han, Shuo;  Xu, Jiaqi;  Hu, Guang; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.0 | Submit date:2024/01/02
Car-t  Clinical Trials  Dual-target  Target Profiling  
Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials. Conference paper
Zhang, Daiyan, Lyu, Liyang, HU YUANJIA. Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials.[C], 2023.
Authors:  Zhang, Daiyan;  Lyu, Liyang;  HU YUANJIA
Favorite |  | Submit date:2024/01/02
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:  Yang, Jing;  Kang, Heming;  Lyu, Liyang;  Xiong, Wei;  Hu, Yuanjia
Favorite | TC[WOS]:7 TC[Scopus]:7 | Submit date:2023/09/21
Bispecific Antibodies  Combination Therapy  Immuno-oncology Therapy  Kinase Inhibitors  Pd-1/pd-l1 Inhibitors  Targeted Therapy  
The Financial Impact of Patents on SMEs in China: Empirical Evidence from Pharmaceutical Sector Journal article
Feng, Ye, Liu, Kunmeng, Lyu, Liyang, Sun, Guojun, Hu, Yuanjia. The Financial Impact of Patents on SMEs in China: Empirical Evidence from Pharmaceutical Sector[J]. Science, Technology and Society, 2022, 27(1), 46-65.
Authors:  Feng, Ye;  Liu, Kunmeng;  Lyu, Liyang;  Sun, Guojun;  Hu, Yuanjia
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:1.7/2.0 | Submit date:2022/03/28
Small And Medium-sized Enterprises (Smes)  Open Innovation  Intellectual Property  Financial Performance  Patent Quantity And Quality  
The internationalization of TCM towards Portuguese-speaking countries Journal article
Xiaoting Zheng, Liyang Lyu, Hong Lu, Yuanjia Hu, Ging Chan. The internationalization of TCM towards Portuguese-speaking countries[J]. Chinese Medicine, 2021, 16(1), 81.
Authors:  Xiaoting Zheng;  Liyang Lyu;  Hong Lu;  Yuanjia Hu;  Ging Chan
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.3/5.5 | Submit date:2022/05/13
Traditional Chinese Medicine  Portuguese-speaking Countries  Challenges  Platform Role Of Macau  
A review of cutting-edge therapies for hepatocellular carcinoma (Hcc): Perspectives from patents Journal article
Gao, Yan, Lyu, Liyang, Feng, Ye, Li, Fei, Hu, Yuanjia. A review of cutting-edge therapies for hepatocellular carcinoma (Hcc): Perspectives from patents[J]. International Journal of Medical Sciences, 2021, 18(14), 3066-3081.
Authors:  Gao, Yan;  Lyu, Liyang;  Feng, Ye;  Li, Fei;  Hu, Yuanjia
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:3.2/3.4 | Submit date:2022/05/13
Ablation  Trans Artery Chemoembolization (Tace)  Radiotherapy  T-cell  Notch Pathway  
The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape Journal article
Lyu,Liyang, Feng,Ye, Chen,Xin, Hu,Yuanjia. The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape[J]. Nature Biotechnology, 2020, 38(12), 1387-1394.
Authors:  Lyu,Liyang;  Feng,Ye;  Chen,Xin;  Hu,Yuanjia
Favorite | TC[WOS]:19 TC[Scopus]:19  IF:33.1/56.9 | Submit date:2021/03/01